How should naproxen be administered?

How to Administer Naproxen

Naproxen should be administered orally at the lowest effective dose for the shortest duration, with dosing frequency and amount determined by the specific condition being treated. 1

Standard Dosing Regimens by Indication

For Chronic Inflammatory Conditions (Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis)

• Standard dose: 250 mg, 375 mg, or 500 mg twice daily 1
• The morning and evening doses do not need to be equal
• For patients tolerating lower doses well, may increase up to 1500 mg/day for limited periods (up to 6 months) when higher anti-inflammatory activity is required 1
• Dosing more frequently than twice daily does not generally improve response 1

For Acute Pain Conditions (Primary Dysmenorrhea, Acute Tendonitis/Bursitis, Post-operative Pain)

• Initial dose: 500 mg naproxen (or 550 mg naproxen sodium for faster onset)
• Maintenance: 500 mg every 12 hours OR 250 mg every 6-8 hours as needed 1
• Maximum first day: 1250 mg total
• Maximum subsequent days: 1000 mg total 1
• Naproxen sodium is preferred for acute pain when rapid onset is desired (pain relief begins within 30 minutes vs. 1 hour for regular naproxen) 1

For Acute Gout

• Initial dose: 750 mg
• Maintenance: 250 mg every 8 hours until attack subsides 1

For Juvenile Arthritis

• Dose: Approximately 10 mg/kg/day divided into 2 doses (5 mg/kg twice daily) 1
• Naproxen oral suspension is recommended over tablets for this indication 1

Special Population Considerations

Elderly Patients (≥65 years)

• Use the lowest effective dose and consider starting at lower end of dosing range 1
• For non-prescription use in osteoarthritis: 440 mg/day (vs. 660 mg/day for younger patients) 2
• Although total plasma concentration is unchanged, unbound fraction increases with age, requiring dose adjustment when high doses are needed 1

Renal Impairment

• Contraindicated in moderate to severe renal impairment (creatinine clearance <30 mL/min) 1
• Consider lower doses in mild renal impairment 1

Hepatic Impairment

• Consider lower starting doses and titrate based on response 1

Administration Timing and Formulation Considerations

Key point: Different formulations (tablets, suspension, delayed-release, naproxen sodium) have pharmacokinetic differences affecting onset of action, though all circulate as naproxen 1. These are not bioequivalent and this must be considered when switching formulations 1.

Timing Strategy

• For acute pain: Administer as soon as pain begins for optimal effect
• Preoperative vs. postoperative: Both are equally effective—naproxen sodium 550 mg given 30 minutes postoperatively is as effective as preoperative administration 3
• For chronic conditions: Can be given as single daily dose (500 mg at night) without loss of efficacy in osteoarthritis 4

Critical Safety Precautions

Gastrointestinal Protection

When prescribing naproxen, assess GI risk factors 5:

• High-risk patients (history of GI bleeding, age >75, concurrent anticoagulants/steroids): Combine with proton pump inhibitor or consider COX-2 inhibitor 5, 6
• Moderate-risk patients (age 65-75, dyspepsia history): Consider PPI co-therapy 5

Cardiovascular Considerations

• Avoid in patients with congestive heart failure 5
• Use with caution in hypertension (can increase blood pressure by mean of 5 mmHg) 5
• Evidence on naproxen's cardiovascular effects is conflicting—some studies suggest cardioprotection, others show no effect 6

Duration Limits

Use the shortest duration consistent with treatment goals 1. This is critical to minimize risks of GI bleeding, cardiovascular events, and medication overuse (particularly important in headache disorders—limit to maximum 2 days per week to prevent medication overuse headache) 7.

Common Pitfalls to Avoid

1. Do not combine with aspirin or other NSAIDs—aspirin increases naproxen excretion and combination increases adverse event frequency without added benefit 1
2. Do not assume all doses/formulations are interchangeable—naproxen sodium acts faster than naproxen base 1
3. Do not exceed maximum daily doses—this significantly increases adverse events without proportional benefit 1
4. Do not forget renal screening—contraindicated in moderate-severe renal impairment 1